High-dose oral baclofen: experience in patients with multiple sclerosis
- PMID: 1944915
- DOI: 10.1212/wnl.41.11.1829
High-dose oral baclofen: experience in patients with multiple sclerosis
Abstract
We reviewed a 10% random sample of charts from an outpatient clinic for multiple sclerosis to determine the frequency with which baclofen was prescribed for spasticity in high doses (greater than 80 mg/d). About 20% of patients had taken high-dose baclofen, and 15% were still receiving a high dose. Taking a high dose was not associated with discontinuing treatment.
Comment in
-
Baclofen for spasticity.Neurology. 1992 Oct;42(10):2056. doi: 10.1212/wnl.42.10.2056-a. Neurology. 1992. PMID: 1407599 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical